Similar articles

• Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.

  Copeman M. Copeman M. Med J Aust. 2003 Jul 21;179(2):119; author reply 119. Med J Aust. 2003. PMID: 12864712 No abstract available.
• The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.

  Sullivan LG. Sullivan LG. Med J Aust. 1999 Aug 2;171(3):165-6. Med J Aust. 1999. PMID: 10474613 No abstract available.
• Modelling the hepatitis C virus epidemic in Australia.

  Razali K, Thein HH, Bell J, Cooper-Stanbury M, Dolan K, Dore G, George J, Kaldor J, Karvelas M, Li J, Maher L, McGregor S, Hellard M, Poeder F, Quaine J, Stewart K, Tyrrell H, Weltman M, Westcott O, Wodak A, Law M. Razali K, et al. Drug Alcohol Depend. 2007 Dec 1;91(2-3):228-35. doi: 10.1016/j.drugalcdep.2007.05.026. Epub 2007 Jul 31. Drug Alcohol Depend. 2007. PMID: 17669601
• Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

  Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Birkhead GS, et al. Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20. Int J Drug Policy. 2007. PMID: 17854731 Review.
• The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.

  Islam M, Wodak A, Conigrave KM. Islam M, et al. Int J Drug Policy. 2008 Dec;19(6):436-41. doi: 10.1016/j.drugpo.2007.07.006. Epub 2007 Sep 4. Int J Drug Policy. 2008. PMID: 17766100 Review.